This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, R.
Right arrow Articles by Wisdom, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, R.
Right arrow Articles by Wisdom, R.

 Previous Article  |  Next Article 

Mol. Cell. Biol., 08 1996, 4504-4511, Vol 16, No. 8
Copyright © 1996, American Society for Microbiology

Cellular transformation and malignancy induced by ras require c-jun

R Johnson, B Spiegelman, D Hanahan and R Wisdom
Hormone Research Institute, University of California, San Francisco 94143, USA.

ras is an important oncogene in experimental animals and humans. In addition, activated ras proteins are potent inducers of the transcription factor AP-1, which is composed of heterodimeric complexes of Fos and Jun proteins. Together with the fact that deregulated expression of some AP-1 proteins can cause neoplastic transformation, this finding suggests that AP-1 may function as a critical ras effector. We have tested this hypothesis directly by analyzing the response to activated ras in cells that harbor a null mutation in the c- jun gene. The transcriptional response of AP-1-responsive genes to activated ras is severely impaired in c-jun null fibroblasts. Compared with wild-type cells, the c-jun null cells lack many characteristics of ras transformation, including loss of contact inhibition, anchorage independence, and tumorigenicity in nude mice; these properties are restored by forced expression of c-jun. Rare tumorigenic variants of ras-expressing c-jun null fibroblasts do arise. Analysis of these variants reveals a consistent restoration of AP-1 activity. The results provide genetic evidence that c-jun is a crucial effector for transformation by activated ras proteins.


This article has been cited by other articles:

  • Agger, K., Cloos, P. A.C., Rudkjaer, L., Williams, K., Andersen, G., Christensen, J., Helin, K. (2009). The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence. Genes Dev. 23: 1171-1176 [Abstract] [Full Text]  
  • Choi, H. S., Bode, A. M., Shim, J.-H., Lee, S.-Y., Dong, Z. (2009). c-Jun N-Terminal Kinase 1 Phosphorylates Myt1 To Prevent UVA-Induced Skin Cancer. Mol. Cell. Biol. 29: 2168-2180 [Abstract] [Full Text]  
  • Su, Z.-z., Lee, S.-G., Emdad, L., Lebdeva, I. V., Gupta, P., Valerie, K., Sarkar, D., Fisher, P. B. (2008). Cloning and characterization of SARI (suppressor of AP-1, regulated by IFN). Proc. Natl. Acad. Sci. USA 105: 20906-20911 [Abstract] [Full Text]  
  • Ouyang, X., Jessen, W. J., Al-Ahmadie, H., Serio, A. M., Lin, Y., Shih, W.-J., Reuter, V. E., Scardino, P. T., Shen, M. M., Aronow, B. J., Vickers, A. J., Gerald, W. L., Abate-Shen, C. (2008). Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer. Cancer Res. 68: 2132-2144 [Abstract] [Full Text]  
  • Holmstrom, T. H., Mialon, A., Kallio, M., Nymalm, Y., Mannermaa, L., Holm, T., Johansson, H., Black, E., Gillespie, D., Salminen, T. A., Langel, U., Valdez, B. C., Westermarck, J. (2008). c-Jun Supports Ribosomal RNA Processing and Nucleolar Localization of RNA Helicase DDX21. J. Biol. Chem. 283: 7046-7053 [Abstract] [Full Text]  
  • Choi, H. S., Kang, B. S., Shim, J.-H., Cho, Y.-Y., Choi, B. Y., Bode, A. M., Dong, Z. (2008). Cot, a novel kinase of histone H3, induces cellular transformation through up-regulation of c-fos transcriptional activity. FASEB J. 22: 113-126 [Abstract] [Full Text]  
  • Vasudevan, K. M., Burikhanov, R., Goswami, A., Rangnekar, V. M. (2007). Suppression of PTEN Expression Is Essential for Antiapoptosis and Cellular Transformation by Oncogenic Ras. Cancer Res. 67: 10343-10350 [Abstract] [Full Text]  
  • Qi, X., Pohl, N. M., Loesch, M., Hou, S., Li, R., Qin, J.-Z., Cuenda, A., Chen, G. (2007). p38{alpha} Antagonizes p38{gamma} Activity through c-Jun-dependent Ubiquitin-proteasome Pathways in Regulating Ras Transformation and Stress Response. J. Biol. Chem. 282: 31398-31408 [Abstract] [Full Text]  
  • Ritchie, K. J., Henderson, C. J., Wang, X. J., Vassieva, O., Carrie, D., Farmer, P. B., Gaskell, M., Park, K., Wolf, C. R. (2007). Glutathione Transferase {pi} Plays a Critical Role in the Development of Lung Carcinogenesis following Exposure to Tobacco-Related Carcinogens and Urethane. Cancer Res. 67: 9248-9257 [Abstract] [Full Text]  
  • Wu, K., Liu, M., Li, A., Donninger, H., Rao, M., Jiao, X., Lisanti, M. P., Cvekl, A., Birrer, M., Pestell, R. G. (2007). Cell Fate Determination Factor DACH1 Inhibits c-Jun-induced Contact-independent Growth. Mol. Biol. Cell 18: 755-767 [Abstract] [Full Text]  
  • Sharkey, J., Khong, T., Spencer, A. (2007). PKC412 demonstrates JNK-dependent activity against human multiple myeloma cells. Blood 109: 1712-1719 [Abstract] [Full Text]  
  • Li, Q.-P., Qi, X., Pramanik, R., Pohl, N. M., Loesch, M., Chen, G. (2007). Stress-induced c-Jun-dependent Vitamin D Receptor (VDR) Activation Dissects the Non-classical VDR Pathway from the Classical VDR Activity. J. Biol. Chem. 282: 1544-1551 [Abstract] [Full Text]  
  • Nielsen, C., Thastrup, J., Bottzauw, T., Jaattela, M., Kallunki, T. (2007). c-Jun NH2-Terminal Kinase 2 Is Required for Ras Transformation Independently of Activator Protein 1. Cancer Res. 67: 178-185 [Abstract] [Full Text]  
  • Adiseshaiah, P., Kalvakolanu, D. V., Reddy, S. P. (2006). A JNK-Independent Signaling Pathway Regulates TNF{alpha}-Stimulated, c-Jun-Driven FRA-1 Protooncogene Transcription in Pulmonary Epithelial Cells. J. Immunol. 177: 7193-7202 [Abstract] [Full Text]  
  • Cui, J., Han, S.-Y., Wang, C., Su, W., Harshyne, L., Holgado-Madruga, M., Wong, A. J. (2006). c-Jun NH2-Terminal Kinase 2{alpha}2 Promotes the Tumorigenicity of Human Glioblastoma Cells.. Cancer Res. 66: 10024-10031 [Abstract] [Full Text]  
  • Kravchenko, V. V., Kaufmann, G. F., Mathison, J. C., Scott, D. A., Katz, A. Z., Wood, M. R., Brogan, A. P., Lehmann, M., Mee, J. M., Iwata, K., Pan, Q., Fearns, C., Knaus, U. G., Meijler, M. M., Janda, K. D., Ulevitch, R. J. (2006). N-(3-Oxo-acyl)homoserine Lactones Signal Cell Activation through a Mechanism distinct from the Canonical Pathogen-associated Molecular Pattern Recognition Receptor Pathways. J. Biol. Chem. 281: 28822-28830 [Abstract] [Full Text]  
  • Laderoute, K. R., Amin, K., Calaoagan, J. M., Knapp, M., Le, T., Orduna, J., Foretz, M., Viollet, B. (2006). 5'-AMP-Activated Protein Kinase (AMPK) Is Induced by Low-Oxygen and Glucose Deprivation Conditions Found in Solid-Tumor Microenvironments.. Mol. Cell. Biol. 26: 5336-5347 [Abstract] [Full Text]  
  • Kakumoto, K., Sasai, K., Sukezane, T., Oneyama, C., Ishimaru, S., Shibutani, K., Mizushima, H., Mekada, E., Hanafusa, H., Akagi, T. (2006). FRA1 is a determinant for the difference in RAS-induced transformation between human and rat fibroblasts. Proc. Natl. Acad. Sci. USA 103: 5490-5495 [Abstract] [Full Text]  
  • Wu, B., Ootani, A., Iwakiri, R., Sakata, Y., Fujise, T., Amemori, S., Yokoyama, F., Tsunada, S., Toda, S., Fujimoto, K. (2006). T Cell Deficiency Leads to Liver Carcinogenesis in Azoxymethane-Treated Rats. Exp. Biol. Med. 231: 91-98 [Abstract] [Full Text]  
  • Tang, J., Qi, X., Mercola, D., Han, J., Chen, G. (2005). Essential Role of p38{gamma} in K-Ras Transformation Independent of Phosphorylation. J. Biol. Chem. 280: 23910-23917 [Abstract] [Full Text]  
  • Thomas, E. K., Nakamura, M., Wienke, D., Isacke, C. M., Pozzi, A., Liang, P. (2005). Endo180 Binds to the C-terminal Region of Type I Collagen. J. Biol. Chem. 280: 22596-22605 [Abstract] [Full Text]  
  • Mialon, A., Sankinen, M., Soderstrom, H., Junttila, T. T., Holmstrom, T., Koivusalo, R., Papageorgiou, A. C., Johnson, R. S., Hietanen, S., Elenius, K., Westermarck, J. (2005). DNA Topoisomerase I Is a Cofactor for c-Jun in the Regulation of Epidermal Growth Factor Receptor Expression and Cancer Cell Proliferation. Mol. Cell. Biol. 25: 5040-5051 [Abstract] [Full Text]  
  • Mack, F. A., Patel, J. H., Biju, M. P., Haase, V. H., Simon, M. C. (2005). Decreased Growth of Vhl-/- Fibrosarcomas Is Associated with Elevated Levels of Cyclin Kinase Inhibitors p21 and p27. Mol. Cell. Biol. 25: 4565-4578 [Abstract] [Full Text]  
  • Kayahara, M., Wang, X., Tournier, C. (2005). Selective Regulation of c-jun Gene Expression by Mitogen-Activated Protein Kinases via the 12-O-Tetradecanoylphorbol-13-Acetate- Responsive Element and Myocyte Enhancer Factor 2 Binding Sites. Mol. Cell. Biol. 25: 3784-3792 [Abstract] [Full Text]  
  • Katabami, M., Donninger, H., Hommura, F., Leaner, V. D., Kinoshita, I., Chick, J. F. B., Birrer, M. J. (2005). Cyclin A Is a c-Jun Target Gene and Is Necessary for c-Jun-induced Anchorage-independent Growth in RAT1a Cells. J. Biol. Chem. 280: 16728-16738 [Abstract] [Full Text]  
  • Shuman, J. D., Sebastian, T., Kaldis, P., Copeland, T. D., Zhu, S., Smart, R. C., Johnson, P. F. (2004). Cell Cycle-Dependent Phosphorylation of C/EBP{beta} Mediates Oncogenic Cooperativity between C/EBP{beta} and H-RasV12. Mol. Cell. Biol. 24: 7380-7391 [Abstract] [Full Text]  
  • Kielosto, M., Nummela, P., Katainen, R., Leaner, V., Birrer, M. J., Holtta, E. (2004). Reversible Regulation of the Transformed Phenotype of Ornithine Decarboxylase- and Ras-Overexpressing Cells by Dominant-Negative Mutants of c-Jun. Cancer Res. 64: 3772-3779 [Abstract] [Full Text]  
  • Qi, X., Tang, J., Pramanik, R., Schultz, R. M., Shirasawa, S., Sasazuki, T., Han, J., Chen, G. (2004). p38 MAPK Activation Selectively Induces Cell Death in K-ras-mutated Human Colon Cancer Cells through Regulation of Vitamin D Receptor. J. Biol. Chem. 279: 22138-22144 [Abstract] [Full Text]  
  • Takenaka, Y., Fukumori, T., Yoshii, T., Oka, N., Inohara, H., Kim, H.-R. C., Bresalier, R. S., Raz, A. (2004). Nuclear Export of Phosphorylated Galectin-3 Regulates Its Antiapoptotic Activity in Response to Chemotherapeutic Drugs. Mol. Cell. Biol. 24: 4395-4406 [Abstract] [Full Text]  
  • Young, A. P., Longmore, G. D. (2004). Ras Protects Rb Family Null Fibroblasts from Cell Death: A ROLE FOR AP-1. J. Biol. Chem. 279: 10931-10938 [Abstract] [Full Text]  
  • An, J., Sun, Y., Rettig, M. B. (2004). Transcriptional coactivation of c-Jun by the KSHV-encoded LANA. Blood 103: 222-228 [Abstract] [Full Text]  
  • Vial, E., Marshall, C. J. (2003). Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells. J. Cell Sci. 116: 4957-4963 [Abstract] [Full Text]  
  • Szremska, A. P., Kenner, L., Weisz, E., Ott, R. G., Passegue, E., Artwohl, M., Freissmuth, M., Stoxreiter, R., Theussl, H.-C., Parzer, S. B., Moriggl, R., Wagner, E. F., Sexl, V. (2003). JunB inhibits proliferation and transformation in B-lymphoid cells. Blood 102: 4159-4165 [Abstract] [Full Text]  
  • Kennedy, N. J., Sluss, H. K., Jones, S. N., Bar-Sagi, D., Flavell, R. A., Davis, R. J. (2003). Suppression of Ras-stimulated transformation by the JNK signal transduction pathway. Genes Dev. 17: 629-637 [Abstract] [Full Text]  
  • Pruitt, K., Pruitt, W. M., Bilter, G. K., Westwick, J. K., Der, C. J. (2002). Raf-independent Deregulation of p38 and JNK Mitogen-activated Protein Kinases Are Critical for Ras Transformation. J. Biol. Chem. 277: 31808-31817 [Abstract] [Full Text]  
  • Behre, G., Singh, S. M., Liu, H., Bortolin, L. T., Christopeit, M., Radomska, H. S., Rangatia, J., Hiddemann, W., Friedman, A. D., Tenen, D. G. (2002). Ras Signaling Enhances the Activity of C/EBPalpha to Induce Granulocytic Differentiation by Phosphorylation of Serine 248. J. Biol. Chem. 277: 26293-26299 [Abstract] [Full Text]  
  • Hu, Y.-F., Li, R. (2002). JunB potentiates function of BRCA1 activation domain 1 (AD1) through a coiled-coil-mediated interaction. Genes Dev. 16: 1509-1517 [Abstract] [Full Text]  
  • Laderoute, K. R., Calaoagan, J. M., Gustafson-Brown, C., Knapp, A. M., Li, G.-C., Mendonca, H. L., Ryan, H. E., Wang, Z., Johnson, R. S. (2002). The Response of c-Jun/AP-1 to Chronic Hypoxia Is Hypoxia-Inducible Factor 1{alpha} Dependent. Mol. Cell. Biol. 22: 2515-2523 [Abstract] [Full Text]  
  • Shields, J. M., Rogers-Graham, K., Der, C. J. (2002). Loss of Transgelin in Breast and Colon Tumors and in RIE-1 Cells by Ras Deregulation of Gene Expression through Raf-independent Pathways. J. Biol. Chem. 277: 9790-9799 [Abstract] [Full Text]  
  • Hennigan, R. F., Stambrook, P. J. (2001). Dominant Negative c-jun Inhibits Activation of the Cyclin D1 and Cyclin E Kinase Complexes. Mol. Biol. Cell 12: 2352-2363 [Abstract] [Full Text]  
  • Leppa, S., Eriksson, M., Saffrich, R., Ansorge, W., Bohmann, D. (2001). Complex Functions of AP-1 Transcription Factors in Differentiation and Survival of PC12 Cells. Mol. Cell. Biol. 21: 4369-4378 [Abstract] [Full Text]  
  • Seagroves, T. N., Ryan, H. E., Lu, H., Wouters, B. G., Knapp, M., Thibault, P., Laderoute, K., Johnson, R. S. (2001). Transcription Factor HIF-1 Is a Necessary Mediator of the Pasteur Effect in Mammalian Cells. Mol. Cell. Biol. 21: 3436-3444 [Abstract] [Full Text]  
  • de Ruiter, N. D., Wolthuis, R. M. F., van Dam, H., Burgering, B. M. T., Bos, J. L. (2000). Ras-Dependent Regulation of c-Jun Phosphorylation Is Mediated by the Ral Guanine Nucleotide Exchange Factor-Ral Pathway. Mol. Cell. Biol. 20: 8480-8488 [Abstract] [Full Text]  
  • Paasinen-Sohns, A., Kielosto, M., Kaariainen, E., Eloranta, T., Laine, A., Janne, O. A., Birrer, M. J., Holtta, E. (2000). C-Jun Activation-Dependent Tumorigenic Transformation Induced Paradoxically by Overexpression or Block of S-Adenosylmethionine Decarboxylase. JCB 151: 801-810 [Abstract] [Full Text]  
  • Chiappetta, G., Tallini, G., De Biasio, M. C., Pentimalli, F., de Nigris, F., Losito, S., Fedele, M., Battista, S., Verde, P., Santoro, M., Fusco, A. (2000). FRA-1 Expression in Hyperplastic and Neoplastic Thyroid Diseases. Clin. Cancer Res. 6: 4300-4306 [Abstract] [Full Text]  
  • Grunstein, J., Masbad, J. J., Hickey, R., Giordano, F., Johnson, R. S. (2000). Isoforms of Vascular Endothelial Growth Factor Act in a Coordinate Fashion To Recruit and Expand Tumor Vasculature. Mol. Cell. Biol. 20: 7282-7291 [Abstract] [Full Text]  
  • Ryan, H. E., Poloni, M., McNulty, W., Elson, D., Gassmann, M., Arbeit, J. M., Johnson, R. S. (2000). Hypoxia-inducible Factor-1{{alpha}} Is a Positive Factor in Solid Tumor Growth. Cancer Res. 60: 4010-4015 [Abstract] [Full Text]  
  • Xiao, L., Lang, W. (2000). A Dominant Role for the c-Jun NH2-Terminal Kinase in Oncogenic Ras-induced Morphologic Transformation of Human Lung Carcinoma Cells. Cancer Res. 60: 400-408 [Abstract] [Full Text]  
  • Thepot, D, Weitzman, J., Barra, J, Segretain, D, Stinnakre, M., Babinet, C, Yaniv, M (2000). Targeted disruption of the murine junD gene results in multiple defects in male reproductive function. Development 127: 143-153 [Abstract]  
  • Rowinsky, E. K., Windle, J. J., Von Hoff, D. D. (1999). Ras Protein Farnesyltransferase: A Strategic Target for Anticancer Therapeutic Development. JCO 17: 3631-3652 [Abstract] [Full Text]  
  • Brabletz, T., Jung, A., Dag, S., Hlubek, F., Kirchner, T. (1999). {beta}-Catenin Regulates the Expression of the Matrix Metalloproteinase-7 in Human Colorectal Cancer. Am. J. Pathol. 155: 1033-1038 [Abstract] [Full Text]  
  • Oktay, M., Wary, K. K., Dans, M., Birge, R. B., Giancotti, F. G. (1999). Integrin-mediated Activation of Focal Adhesion Kinase Is Required for Signaling to Jun NH2-terminal Kinase and Progression through the G1 Phase of the Cell Cycle. JCB 145: 1461-1470 [Abstract] [Full Text]  
  • Hartkamp, J., Troppmair, J., Rapp, U. R. (1999). The JNK/SAPK Activator Mixed Lineage Kinase 3 (MLK3) Transforms NIH 3T3 Cells in a MEK-dependent Fashion. Cancer Res. 59: 2195-2202 [Abstract] [Full Text]  
  • Laderoute, K. R., Mendonca, H. L., Calaoagan, J. M., Knapp, A. M., Giaccia, A. J., Stork, P. J. S. (1999). Mitogen-activated Protein Kinase Phosphatase-1 (MKP-1) Expression Is Induced by Low Oxygen Conditions Found in Solid Tumor Microenvironments. A CANDIDATE MKP FOR THE INACTIVATION OF HYPOXIA-INDUCIBLE STRESS-ACTIVATED PROTEIN KINASE/c-Jun N-TERMINAL PROTEIN KINASE ACTIVITY. J. Biol. Chem. 274: 12890-12897 [Abstract] [Full Text]  
  • Grunstein, J., Roberts, W. G., Mathieu-Costello, O., Hanahan, D., Johnson, R. S. (1999). Tumor-derived Expression of Vascular Endothelial Growth Factor Is a Critical Factor in Tumor Expansion and Vascular Function. Cancer Res. 59: 1592-1598 [Abstract] [Full Text]  
  • Schreiber, M., Kolbus, A., Piu, F., Szabowski, A., Möhle-Steinlein, U., Tian, J., Karin, M., Angel, P., Wagner, E. F. (1999). Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev. 13: 607-619 [Abstract] [Full Text]  
  • Behre, G., Whitmarsh, A. J., Coghlan, M. P., Hoang, T., Carpenter, C. L., Zhang, D.-E., Davis, R. J., Tenen, D. G. (1999). c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor. J. Biol. Chem. 274: 4939-4946 [Abstract] [Full Text]  
  • Janulis, M., Silberman, S., Ambegaokar, A., Gutkind, J. S., Schultz, R. M. (1999). Role of Mitogen-activated Protein Kinases and c-Jun/AP-1 trans-Activating Activity in the Regulation of Protease mRNAs and the Malignant Phenotype in NIH 3T3 Fibroblasts. J. Biol. Chem. 274: 801-813 [Abstract] [Full Text]  
  • Cook, S. J., Aziz, N., McMahon, M. (1999). The Repertoire of Fos and Jun Proteins Expressed during the G1 Phase of the Cell Cycle Is Determined by the Duration of Mitogen-Activated Protein Kinase Activation. Mol. Cell. Biol. 19: 330-341 [Abstract] [Full Text]  
  • Le-Niculescu, H., Bonfoco, E., Kasuya, Y., Claret, F.-X., Green, D. R., Karin, M. (1999). Withdrawal of Survival Factors Results in Activation of the JNK Pathway in Neuronal Cells Leading to Fas Ligand Induction and Cell Death. Mol. Cell. Biol. 19: 751-763 [Abstract] [Full Text]  
  • Malliri, A., Symons, M., Hennigan, R. F., Hurlstone, A. F.L., Lamb, R. F., Wheeler, T., Ozanne, B. W. (1998). The Transcription Factor AP-1 Is Required for EGF-induced Activation of Rho-like GTPases, Cytoskeletal Rearrangements, Motility, and In Vitro Invasion of A431 Cells. JCB 143: 1087-1099 [Abstract] [Full Text]  
  • Zhang, R., Averboukh, L., Zhu, W., Zhang, H., Jo, H., Dempsey, P. J., Coffey, R. J., Pardee, A. B., Liang, P. (1998). Identification of rCop-1, a New Member of the CCN Protein Family, as a Negative Regulator for Cell Transformation. Mol. Cell. Biol. 18: 6131-6141 [Abstract] [Full Text]  
  • Burgess, G. S., Williamson, E. A., Cripe, L. D., Litz-Jackson, S., Bhatt, J. A., Stanley, K., Stewart, M. J., Kraft, A. S., Nakshatri, H., Boswell, H. S. (1998). Regulation of the c-jun Gene in p210 BCR-ABL Transformed Cells Corresponds With Activity of JNK, the c-jun N-Terminal Kinase. Blood 92: 2450-2460 [Abstract] [Full Text]  
  • Li, J., Smithgall, T. E. (1998). Fibroblast Transformation by Fps/Fes Tyrosine Kinases Requires Ras, Rac, and Cdc42 and Induces Extracellular Signal-regulated and c-Jun N-terminal Kinase Activation. J. Biol. Chem. 273: 13828-13834 [Abstract] [Full Text]  
  • Mayo, M. W., Wang, C., Cogswell, P. C., Rogers-Graham, K. S., Lowe, S. W., Der, C. J., Baldwin Jr., A. S. (1997). Requirement of NF-kappa B Activation to Suppress p53-Independent Apoptosis Induced by Oncogenic Ras. Science 278: 1812-1815 [Abstract] [Full Text]  
  • Finco, T. S., Westwick, J. K., Norris, J. L., Beg, A. A., Der, C. J., Baldwin Jr., A. S. (1997). Oncogenic Ha-Ras-induced Signaling Activates NF-kappa B Transcriptional Activity, Which Is Required for Cellular Transformation. J. Biol. Chem. 272: 24113-24116 [Abstract] [Full Text]  
  • Olive, M., Krylov, D., Echlin, D. R., Gardner, K., Taparowsky, E., Vinson, C. (1997). A Dominant Negative to Activation Protein-1 (AP1) That Abolishes DNA Binding and Inhibits Oncogenesis. J. Biol. Chem. 272: 18586-18594 [Abstract] [Full Text]  
  • Foltz, I. N., Schrader, J. W. (1997). Activation of the Stress-Activated Protein Kinases by Multiple Hematopoietic Growth Factors With the Exception of Interleukin-4. Blood 89: 3092-3096 [Abstract] [Full Text]  
  • Clark, G. J., Westwick, J. K., Der, C. J. (1997). p120 GAP Modulates Ras Activation of Jun Kinases and Transformation. J. Biol. Chem. 272: 1677-1681 [Abstract] [Full Text]  
  • Meyer-ter-Vehn, T., Covacci, A., Kist, M., Pahl, H. L. (2000). Helicobacter pylori Activates Mitogen-activated Protein Kinase Cascades and Induces Expression of the Proto-oncogenes c-fos and c-jun. J. Biol. Chem. 275: 16064-16072 [Abstract] [Full Text]  
  • Chen, G., Hitomi, M., Han, J., Stacey, D. W. (2000). The p38 Pathway Provides Negative Feedback for Ras Proliferative Signaling. J. Biol. Chem. 275: 38973-38980 [Abstract] [Full Text]  
  • Qiao, D., Chen, W., Stratagoules, E. D., Martinez, J. D. (2000). Bile Acid-induced Activation of Activator Protein-1 Requires Both Extracellular Signal-regulated Kinase and Protein Kinase C Signaling. J. Biol. Chem. 275: 15090-15098 [Abstract] [Full Text]